Bond.az White LogoBond.az Black Logo

H.C. Wainwright Upgrades Circle Stock to Buy

H.C. Wainwright upgrades Circle Internet Group stock to Buy, citing ARC token presale and Arc network potential. Price target raised to $150.

Sebastian Young
BySebastian Young- Senior Editor
|
0

H.C. Wainwright upgraded Circle Internet Group (NYSE:CRCL) to Buy from Neutral on Monday and raised its price target to $150 from $85. The stock currently trades at $114.

The upgrade follows the successful presale of the ARC token, the native utility token for Circle's Layer 1 blockchain network Arc. H.C. Wainwright views the value creation opportunity from the Arc network as thesis-changing for Circle shareholders.

The firm said Arc's initial $3 billion fully diluted network value appears undervalued. Near-term results from Circle's core stablecoin business should show stability. Circle's revenue surged 51% in the last twelve months.

New product launches like Circle Agent Stack and greater regulatory clarity for digital assets in the U.S. are expected to drive adoption of USDC. The CLARITY Act cleared the Senate Banking Committee on Thursday.

This article was generated with AI support and reviewed by an editor.

More News
Yesterday / 20:21
|
381

RBC Capital hikes Dominion Resources price target

RBC Capital raises Dominion price target to $72 on NextEra deal. Sector Perform rating maintained with 7% arbitrage spread.

0
Yesterday / 20:20
|
884

BofA raises Candel price target to $9

BofA raises Candel price target to $9 after 39% improvement in prostate cancer survival data.

0
Yesterday / 18:11
|
808

Roblox rebounds on user growth, Needham says

Needham reiterates Roblox Buy rating amid user growth rebound. Stock has 27% upside to $60 target.

0
Yesterday / 17:51
|
287

US Tiger Securities Boosts Baidu Price Target on AI

US Tiger Securities raised Baidu price target to $160 on AI growth. AI revenue now exceeds half of business.

0
Yesterday / 15:50
|
224

AMAT and LRCX stocks defended by Lynx

Lynx Equity defends AMAT and LRCX stocks with bullish price targets of $540 and $325 respectively.

0
Yesterday / 14:45
|
827

DA Davidson Maintains Brunswick Stock Neutral

DA Davidson reaffirms Neutral rating on Brunswick with $76 target. Premium brands strong, value brands weak. Q1 2026 results beat estimates.

0
Yesterday / 14:43
|
834

D.A. Davidson Reaffirms Aebi Schmidt on Strong Orders

D.A. Davidson reaffirms Buy rating on Aebi Schmidt with $15 target. Strong order backlog up 23%. Revenue beats expectations. Get details on Bond.az.

0
Yesterday / 13:32
|
366

Freedom Broker Upgrades Kinross Gold Rating

Freedom Broker upgrades Kinross Gold to Buy with $38 target. Strong cash flow and record margins drive the upgrade.

0
Yesterday / 13:01
|
960

JPMorgan Reiterates Five Below Stock Rating with $306 Target

JPMorgan reiterates Overweight rating on Five Below with $306 price target, implying 43% upside potential.

0
Yesterday / 11:44
|
685

Elmet Stock Gets Overweight Rating

Cantor Fitzgerald starts Elmet Group with Overweight rating and $20 target. Defense and reshoring trends drive outlook.

0
Yesterday / 11:25
|
722

Truist Starts Arcus Biosciences at Buy on RCC Potential

Truist Securities initiates Arcus Biosciences with Buy rating and $35 price target, citing casdatifan's potential in renal cell carcinoma and immunology pipeline.

0
Yesterday / 11:24
|
728

Revolution stock buy rating from Truist

Truist Securities gives Revolution Medicines a buy rating with a $179 price target. Daraxon's potential and company outlook.

0
...